Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics
- PMID: 34247424
- DOI: 10.1111/apt.16461
Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics
Abstract
Background: Alcohol use and alcohol-associated liver disease (ALD) burden are increasing in young individuals.
Aim: To assess host factors associated with this burden.
Methods: National Health and Nutrition Examination Survey (NHANES), National Inpatient Sample (NIS), and United Network for Organ Sharing (UNOS) databases (2006-2016) were used to identify individuals with harmful alcohol use, ALD-related admissions, and ALD-related LT listings respectively.
Results: Of 15 981 subjects in NHANES database, weighted prevalence of harmful alcohol use was 17.7%, 29.3% in <35 years (G1) versus 16.9% in 35-64 years (G2) versus 5.1% in ≥65 years (G3). Alcohol use was about 11 and 4.7 folds higher in G1 and G2 versus G3, respectively. Male gender and Hispanic race associated with harmful alcohol use. Of 593 600 ALD admissions (5%, 77%, and 18% in G1-G3 respectively), acute on chronic liver failure (ACLF) occurred in 7.2%, (7.2 in G2 vs 6.7% in G1 and G3, P < 0.001). After controlling for other variables, ACLF development among ALD hospitalizations was higher by 14% and 10% in G1 and G2 versus G3, respectively. Female gender and Hispanic race were associated with increased ACLF risk by 8% and 17% respectively. Of 20,245 ALD LT listings (3.4%, 84.4%, and 12.2% in G1-G3 respectively), ACLF occurred in 28% candidates. Risk of severe (grade 2 or 3) ACLF was higher by about 1.7 fold in G1, 1.5 fold in females and 20% in Hispanics.
Conclusion: Young age, female gender, and Hispanic race are independently associated with ALD-related burden and ACLF in the United States. If these findings are validated in prospective studies, strategies will be needed to reduce alcohol use in high risk individuals to reduce burden from ALD.
© 2021 John Wiley & Sons Ltd.
Comment in
-
Editorial: trends in alcohol use and alcohol-associated liver disease in the US population-authors' reply.Aliment Pharmacol Ther. 2021 Aug;54(4):513-514. doi: 10.1111/apt.16520. Aliment Pharmacol Ther. 2021. PMID: 34331802 No abstract available.
-
Editorial: trends in alcohol use and alcohol-related liver disease in the US population.Aliment Pharmacol Ther. 2021 Aug;54(4):511-512. doi: 10.1111/apt.16491. Aliment Pharmacol Ther. 2021. PMID: 34331814 No abstract available.
References
REFERENCES
-
- Global status report on alcohol and health. World Health Organization, 2018.
-
- Axley PD, Richardson CT, Singal AK. Epidemiology of alcohol consumption and societal burden of alcoholism and alcoholic liver disease. Clin Liver Dis. 2019;23:39-50.
-
- Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the study of liver diseases. Hepatology. 2020;71:306-333.
-
- The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:245-266.
-
- Caputo F, Domenicali M, Bernardi M. Diagnosis and treatment of alcohol use disorder in patients with end-stage alcoholic liver disease. Hepatology. 2019;70:410-417.
MeSH terms
LinkOut - more resources
Full Text Sources